Alterations in sialic-acid O -acetylation glycoforms during murine erythrocyte development
Preprint
Abstract
9- O -acetylation of sialic acid is a common modification that plays important roles in host-pathogen interactions. CASD1 has been described as a sialate- O -acetyltransferase and has been shown to be essential for 9- O -acetylation of sialic acid in some cell lines in vitro . In this study, we used knockout mice to confirm that CASD1 is indeed responsible for 9- O -acetylation of sialic acids in vivo . We observed a complete loss of 9- O -acetylation of sialic acids on the surface of myeloid, erythroid and CD4 + T cells in Casd1 -deficient mice. Although 9- O -acetylation of sialic acids on multiple hematopoietic lineages was lost, there were no obvious defects in hematopoiesis. Interestingly, red blood cells from Casd1 -deficient mice also lost reactivity to TER-119, a rat monoclonal antibody that is widely used to mark the murine erythroid lineage. The sialic acid glyco-epitope recognized by TER-119 on red blood cells was sensitive to the sialic acid O -acetyl esterase activity of the hemagglutinin esterase from bovine coronavirus but not to the corresponding enzyme from the influenza C virus. During erythrocyte development TER-119 + Ery-A and Ery-B cells could be stained by catalytically inactive bovine coronavirus hemaggutinin-esterase but not by the inactive influenza C hemagglutinin esterase, while TER-119 + Ery-C stage cells and mature erythrocytes were recognized by both virolectins. These results suggest that throughout murine erythrocyte development, cells of the erythroid lineage express a glycoconjugate bearing a modified 7,9-di- O -acetyl form of sialic acid, that is recognized specifically by the bovine coronavirus lectin and not by the influenza C hemagglutinin, and this modified sialic acid moiety is a component of the TER-119 epitope. As erythrocytes mature, the surface of Ery-C cells and mature erythrocytes also acquires a distinct CASD1-dependent 9- O -acetyl sialic acid moiety that can be recognized by virolectins from both influenza C and bovine coronavirus that are specific for 9- O -acetyl sialic acid.Keywords
All Related Versions
- Published version: Glycobiology, 29 (3), 222.
This publication has 14 references indexed in Scilit:
- Coronavirus receptor switch explained from the stereochemistry of protein–carbohydrate interactions and a single mutationProceedings of the National Academy of Sciences, 2016
- Striking Immune Phenotypes in Gene-Targeted Mice Are Driven by a Copy-Number Variant Originating from a Commercially Available C57BL/6 StrainCell Reports, 2016
- 9-O-Acetylation of sialic acids is catalysed by CASD1 via a covalent acetyl-enzyme intermediateNature Communications, 2015
- Complexity and Diversity of the Mammalian Sialome Revealed by Nidovirus VirolectinsCell Reports, 2015
- Tissue-based map of the human proteomeScience, 2015
- Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesisProceedings of the National Academy of Sciences, 2009
- Sialic acids as regulators of molecular and cellular interactionsCurrent Opinion in Structural Biology, 2009
- B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esteraseJournal of Experimental Medicine, 2008
- 9-O-acetylated sialic acids have widespread but selective expression: analysis using a chimeric dual-function probe derived from influenza C hemagglutinin-esterase.Proceedings of the National Academy of Sciences, 1994
- Selective Inactivation of Influenza C Esterase: A Probe for Detecting 9- O -Acetylated Sialic AcidsScience, 1987